Press release: Showtime for Digital Medical Innovations
Full house at the second “BIH Digital Health Accelerator Demo Day” held by the Berlin Institute of Health (BIH)
Full house at the second “BIH Digital Health Accelerator Demo Day” held by the Berlin Institute of Health (BIH)
Researchers from Charité - Universitätsmedizin Berlin and the Berlin Institute of Health (BIH) along with colleagues from the Cleveland Clinic in Ohio, USA have shown that certain bacterial metabolic products in the intestine increase the risk of suffering a heart attack or stroke. This applied, in particular, to patients who had already suffered a…
A team of researchers from the Berlin Institute of Health (BIH) along with colleagues from Hannover and Freiburg have created the interactive website "IntoValue". Visitors to this website can find out how often and how fast the results of over 2,000 clinical trials carried out in Germany with a total participation of over 500,000 patients are…
Casanova, an 18th-century Italian writer, is still famous today for his numerous love affairs with the ladies of his era. The molecular precision tool of the same name, which was developed by scientists from Heidelberg and Berlin, definitely has something in common with its namesake. It seeks out a partner and enters into a close bond, but then…
The CRISPR-Cas9 gene editing system has been generating excitement within the field of gene therapy, inspiring hopes of molecular tools capable of treating genetic diseases. By studying immune responses to CRISPR-Cas9 in humans, researchers from Charité – Universitätsmedizin Berlin have found widespread immunity to the Cas9 protein. The researchers…
Researchers from the Berlin Institute of Health (BIH), Charité – Universitätsmedizin Berlin, Humboldt-Universität zu Berlin and the University of Geneva will study the effects of play on the learning processes inside the brain. The project BrainPlay has been awarded an ERC Synergy Grant by the European Research Council (ERC) amounting to €9.8…
Pilot study indicates genetic damage caused by radiation
New Emmy Noether Independent Junior Research Group at Charité A new Emmy Noether Independent Junior Research Group at Charité – Universitätsmedizin Berlin is studying the development of pediatric cancers. The research group is being funded by the German Research Foundation (DFG) and will receive €1.7 million over five years.
After a successful cooperation in 2017, the Berlin Institute of Health (BIH) is working together with the accelerator program Startupbootcamp Digital Health Berlin again this year. The program supports ten international start-ups annually. The aim is to promote innovations in the field of digital medicine and to make them more easily accessible for…
Charité and BIH develop digital data processing infrastructure
Five research projects of the Berlin Institute of Health (BIH) and the Charité - Universitätsmedizin Berlin were selected from 190 submitted dossiers for the new Sanofi Innovation Awards Europe Program (Sanofi iAwards Europe). Leading BIH and Charité scientists convinced in an international competition with their innovative, translational projects…
The validation fund of Berlin Health Innovations in cooperation with SPARK Berlin is entering its first round. 18 selected teams from the Charité – Universitätsmedizin Berlin and the Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC) will receive intensive mentoring and coaching as well as 3.4 million euros in funding for…
Joint press release by Berlin Institute of Health and Charité – Universtätsmedizin Berlin
Joint press release by Berlin Institute of Health (BIH) and Charité – Universitätsmedizin Berlin
DigiTwins received an invitation from the European Commission to enter the next stage of the competition to become an EU Flagship for Future and Emerging Technologies. DigiTwins, a large research initiative in Europe and beyond aims at revolutionizing healthcare and biomedical research for the benefit of citizens and society and at contributing to…
The appointment of Prof. Dr. Robert Gütig strengthens NeuroCure Cluster of Excellence
Joint press release from Berlin Institute of Health (BIH) and Charité – Universitätsmedizin Berlin.
Charité und BIH berufen Prof. Dr. Irina Lehmann
On April 1, 2018 Professor Roland Eils will take up the professorship for Digital Health at the Berlin Institute of Health (BIH) and the Charité – Universitätsmedizin Berlin. Professor Eils will therefore take responsibility for one of the central scientific topics of the BIH.
An international research team has succeeded in stopping the growth of malignant melanoma by reactivating a protective mechanism that prevents tumor cells from dividing. The team used chemical agents to block the enzymes responsible for erasing epigenetic marks at the DNA. This discovery has potential for use in future combination therapies.
The IT specialist for medicine, Professor Sylvia Thun, will be the new Director for eHealth and Interoperability at Berlin Institute of Health (BIH). The physician and qualified engineer is an expert in national and international IT standards in the health sector. She will develop a new unit for BIH, with the objective of better networking of…
Joint press release from Charité – Universitätsmedizin Berlin, the Berlin Institute of Health, and Einstein Foundation Berlin
Twenty-five years ago, an unusual inherited form of high blood pressure was first described in an Australian family. Its genetic cause, however, had remained elusive. Using modern sequencing methods, an international research team led by BIH Johanna Quandt Professor Ute Scholl has succeeded in detecting mutations in a new disease gene (CLCN2) –…
On January 24 in Berlin, four innovation teams from the Digital Health Accelerator pilot project of Berlin Institute of Health (BIH) and two start-ups from Charité – Universitätsmedizin Berlin presented their digital health solutions for everyday clinical use. The new solutions leverage in particular imaging and big data big data analytical…
What are the consequences if a cellular aging-like program is acutely activated in tumor cells? And what role does the stem cell program play in it? In the journal Nature, a research team at Charité and MDC is publishing its findings on the downsides of drug therapy in cancer treatment.